Nanobiotix (NBTX) Current Leases (2021 - 2023)
Nanobiotix's (NBTX) quarterly Current Leases came in at $1.2 million in Q2 2023, up 3.86% year-on-year from $1.2 million in Q2 2022, and up 3.86% quarter-over-quarter from $1.2 million in Q2 2022.
Nanobiotix (NBTX) Current Leases (2021 - 2023) Analysis & Trends
Nanobiotix's Current Leases history runs 3 years deep, the most recent figure standing at $1.2 million for Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 20.58 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 16.61 Mn |
| 10 | Alnylam Pharmaceuticals | 36.08 Bn | 33.07 Bn | 959.66 Mn | 45.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 1.25 Mn |
| Jun 30, 2022 | 1.20 Mn |
| Jun 30, 2021 | 1.44 Mn |